An unusual non-resolving community-acquired pneumonia

Autores/as

  • Andrea Zappalà Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Silvia Puglisi Pneumologia, Dipartimento Malattie dell’Apparato Respiratorio e del torace, Ospedale Morgagni-Pierantoni, Forlì
  • Ilaria Di Cataldo Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Alessio Trombetta Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Alessio Trombetta Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Federica Lo Bello Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Alfio Proietto Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Irene Coppolino Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina
  • Venerino Poletti Pneumologia, Dipartimento Malattie dell’Apparato Respiratorio e del torace, Ospedale Morgagni-Pierantoni, Forlì
  • Gaetano Caramori Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina

DOI:

https://doi.org/10.13129/1828-6550/APMB.109.2.2021.CCS1

Palabras clave:

non-resolving pneumonia, autoimmune pneumonia, organizing pneumonia, systemic lupus erythematosus, acute lupic pneumonitis.

Resumen

We present the case of a 61-year-old male that was admitted to our Unit of Pulmonology for a suspected community-acquired pneumonia (CAP) with acute hypoxemic respiratory failure. However, despite many courses of empiric wide spectrum antibiotic treatment, the respiratory failure persisted and new bilateral migratory pulmonary opacities and serosal effusions appeared. The most common causes of non-resolving CAP were excluded and the combination of thrombocytopenia, autoimmune hemolysis, pleural and pericardial effusions in a patient with antinuclear antibodies ANA at a titer of 1:160 is diagnostic for systemic lupus erythematosus (SLE)

Referencias

1. Grief, S.N., Loza, J.K. (2018). Guidelines for the evaluation and treatment of pneumonia. Prim Care, 45, 485-503. doi: 10.1016/j.pop.2018.04.001.

2. Metlay, J.P., Waterer, G.W., Long, A.C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L.A., Dean, N.C., Fine, M.J., Flanders, S.A., Griffin, M.R., Metersky, M.L., Musher, D.M., Restrepo, M.I., Whitney, C.G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America: executive summary. Am J RespirCrit Care Med, 200, 809-821. doi: 10.1164/rccm.201908-1581ST.

3. Cordier, J.F., Cottin, V., Lazor, R., Thivolet-Béjui, F. (2016).Many faces of bronchiolitis and organizing pneumonia.SeminRespirCrit Care Med, 37, 421-440. doi: 10.1055/s-0036-1582013.

4. Getahun, H., Matteelli, A., Abubakar, I., Aziz, M.A., Baddeley, A., Barreira, D., DenBoon, S., BorrotoGutierrez, S.M., Bruchfeld, J., Burhan, E., Cavalcante, S., Cedillos, R., Chaisson, R., Chee, C.B., Chesire, L., Corbett, E., Dara, M., Denholm, J., de Vries, G., Falzon, D., Ford, N., Gale-Rowe, M., Gilpin, C., Girardi, E., Go, U.Y., Govindasamy, D., Grant, A., Grzemska, M., Harris, R., Horsburgh, C.R. Jr, Ismayilov, A., Jaramillo, E., Kik, S., Kranzer, K., Lienhardt, C., LoBue, P., Lönnroth, K., Marks, G., Menzies, D., Migliori, G.B., Mosca, D., Mukadi, Y.D., Mwinga, A., Nelson, L., Nishikiori, N., Oordt-Speets, A., Rangaka, M.X., Reis, A., Rotz, L., Sandgren, A., SañéSchepisi, M., Schünemann, H.J., Sharma, S.K., Sotgiu, G., Stagg, H.R., Sterling, T.R., Tayeb, T., Uplekar, M., van der Werf, M.J., Vandevelde, W., van Kessel, F., van'tHoog, A., Varma, J.K., Vezhnina, N., Voniatis, C., VonkNoordegraaf-Schouten, M., Weil, D., Weyer, K., Wilkinson, R.J., Yoshiyama, T., Zellweger, J.P., Raviglione, M. (2015). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. EurRespir J, 46(6): 1563-76. doi: 10.1183/13993003.01245-2015.

5. Cavazza, A., Colby, T.V., Dubini, A., Tomassetti, S., Ravaglia, C., Poletti, V., Mengoli, M.C., Tagliavini, E., Rossi, G. (2020). TransbronchialCryobiopsy in the Diagnosis of Diffuse Lung Disease. SurgPatholClin, 13(1), 197-208. doi: 10.1016/j.path.2019.11.004.

6. Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J.S., Wofsy, D., Boumpas, D.T., Kamen, D.L., Jayne, D., Cervera, R., Costedoat-Chalumeau, N., Diamond, B., Gladman, D.D., Hahn, B., Hiepe, F., Jacobsen, S., Khanna, D., Lerstrøm, K., Massarotti, E., McCune, J., Ruiz-Irastorza, G., Sanchez-Guerrero, J., Schneider, M., Urowitz, M., Bertsias, G., Hoyer, B.F., Leuchten, N., Tani, C., Tedeschi, S.K., Touma, Z., Schmajuk, G., Anic, B., Assan, F., Chan, T.M., Clarke, A.E., Crow, M.K., Czirják, L., Doria, A., Graninger, W., Halda-Kiss, B., Hasni, S., Izmirly, P.M., Jung, M., Kumánovics, G., Mariette, X., Padjen, I., Pego-Reigosa, J.M., Romero-Diaz, J., Rúa-Figueroa Fernández, Í., Seror, R., Stummvoll, G.H., Tanaka, Y., Tektonidou, M.G., Vasconcelos, C., Vital, E.M., Wallace, D.J., Yavuz, S., Meroni, P.L., Fritzler, M.J., Naden, R., Dörner, T., Johnson, S.R. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis, 78(9): 1151-1159. doi: 10.1136/annrheumdis-2018-214819.

7. Nusbaum, J.S., Mirza, I., Shum, J., Freilich, R.W., Cohen, R.E., Pillinger, M.H., Izmirly, P.M., Buyon, J.P. (2020). Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. Mayo ClinProc, 95(2): 384-394. https://doi.org/10.1016/j.mayocp.2019.09.012.

8. Rekvig, O.P. (2020). Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis. Front Immunol, 11: 569234. doi: 10.3389/fimmu.2020.569234

9. Schulte, J.J., Husain, A.N. (2020). Connective Tissue Disease Related Interstitial Lung Disease. SurgPatholClin, 13(1), 165-188. doi: 10.1016/j.path.2019.11.005.

10. Enomoto, N., Egashira, R., Tabata, K., Hashisako, M., Kitani, M., Waseda, Y., Ishizuka, T., Watanabe, S., Kasahara, K., Izumi, S., Shiraki, A., Miyamoto, A., Kishi, K., Kishaba, T., Sugimoto, C., Inoue, Y., Kataoka, K., Kondoh, Y., Tsuchiya, Y., Baba, T., Sugiura, H., Tanaka, T., Sumikawa, H., Suda, T. (2019). Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study. Sci Rep, 9, 7355-7366. doi: 10.1038/s41598-019-43782-7.

11. Wan, S.A., The, C.L., Jobli, A.T. (2016). Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution. Lupus, 0: 1-6. doi:10.1177/0961203316646461.

12. Cantero, C., Vongthilath, R., Plojoux, J. (2020). Acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus. BMJ Case Rep, 13: e234638. doi:10.1136/bcr-2020-234638.

13. Keane, M., Lynch, J. (2000). Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax, 55(2): 159–166. doi: 10.1136/thorax.55.2.159.

Carmiera, D., Marchand-Adama, S., Diota, P., Diotb, E. (2010). Respiratory involvement in systemic lupus erythematosus. Revue des Maladies Respiratoires, 27, e66—e78. doi:10.1016/j.rmr.2010.01.003.

Descargas

Publicado

2021-08-26

Número

Vol. 109 Núm. 2 (2021)

Sección

CLINICAL CASE SEMINAR

Licencia

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).